disease-progression

Documents about disease-progression

• The genesis and progression of the HIV/AIDS programme in KwaZulu-Natal : implications for learning and intensified action#1024236UZSpace
• IL7RA rs10491434 polymorphism is related to spontaneous HIV infection control in naïve HIV-infected patients: A retrospective study.#276166Repisalud
• Assessment of the Safety of Adalimumab in Rheumatoid Arthritis Patients Showing Rapid Progression of Structural Damage of the Joints, Who Have no Prior History of Treatment With Disease-modifying Anti-rheumatic Drugs or Biological Agents#873523ClinicalTrials.gov
• Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance#979776ClinicalTrials.gov
• T cell receptor repertoires associated with control and disease progression following mycobacterium tuberculosis infection#228772SUNScholar
• Effects of a Neuroscience-based Technique on Cancer Patients Announced of a Palliative Disease Progression and Partners#880683ClinicalTrials.gov
• Overlapping SETBP1 gain-of-function mutations in Schinzel-Giedion syndrome and hematologic malignancies#955052Koc University Digital Collections
• Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective Analysis#235078HAL (France)
• Post-treatment serum interleukin-6 is independently associated with disease progression in patients with advanced non-small cell lung cancer and coexisting COPD: a multicenter real-world cohort study#673302ARPHA OAI-PMH Endpoint
• A Study of First-line Maintenance Erlotinib Versus Erlotinib at Disease Progression in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) Who Have Not Progressed Following Platinum-Based Chemotherapy#859549ClinicalTrials.gov
• Natural History Study of Children and Adults With Adrenocortical Cancer (ACC)#892187ClinicalTrials.gov
• Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis#1046419ClinicalTrials.gov
• Longitudinal MRI Assessment in Patients With Diffuse Low-grade Gliomas#839310ClinicalTrials.gov
• The Impact of Fecal Microbiota Transplantation as an Immunomodulation on the Risk Reduction of COVID-19 Disease Progression With Escalating Cytokine Storm and Inflammatory Parameters#884373ClinicalTrials.gov
• MRI and Stable Isotope Tracer Studies for Detecting the Progression of Non-Alcoholic Steatohepatitis (NASH)#888435ClinicalTrials.gov
• AZP2006 in Progressive Supranuclear Palsy: Outcomes from a Phase 2a Multicenter, Randomized Trial, and Open‐Label Extension on Safety, Biomarkers, and Disease Progression#365103Open Access LMU
• A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy#424196ClinicalTrials.gov
• Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients#801925ClinicalTrials.gov
• Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia#862478ClinicalTrials.gov
• Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor#914261ClinicalTrials.gov
• Clinical features of 314 patients with relapsing-remitting multiple sclerosis [Esclerosis múltiple recurrente remitente en el sector público de salud de chile. descripción clínica de 314 pacientes]#947547Repositorio de Universidad Autónoma de Chile.
• Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer#1047199ClinicalTrials.gov
• Severity and Duration-Dependent Aortic Stiffening in a Rabbit Coarctation Model Identifies Constitutive Material Parameters as Promising Regional Biomarkers for Hypertension Progression#200798ODU Digital Commons
• Can resveratrol treatment control the progression of induced periodontal disease? a systematic review and meta-analysis of preclinical studies#1017122RI UFLA
• Firefighter Aged Garlic Extract Investigation With CoQ10 as a Treatment for Heart Disease (FAITH)#807032ClinicalTrials.gov
• To Evaluate the Efficacy of Afatinib in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer With NRG1 Fusion#884369ClinicalTrials.gov
• A Pilot Study of Dacomitinib With or Without Osimertinib for Patients With Metastatic EGFR Mutant Lung Cancers With Disease Progression on Osimertinib.#914034ClinicalTrials.gov
• Data Sheet 7_Analysis of 16S rRNA to evaluate taxonomic differences between salivary and intratumoral microbiota in patients affected by oral squamous cell carcinoma: a single-center pilot study.csv#395105Figshare
• Corrected QT Interval Effects of Trastuzumab Emtansine (T-DM1) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer and the Safety and Tolerability of Combined T-DM1 and Pertuzumab in Patients With Early Disease Progression#848336ClinicalTrials.gov
• Combined Treatment With Fresh Frozen Plasma and Rituximab (Mabthera) in Patients With Advanced Refractory Chronic Lymphocytic Leukemia#845833ClinicalTrials.gov
• A NIS of Alpelisib in Combination With Fulvestrant in Postmenopausal Women, and Men, With HR+,HER2- , Locally Advanced or Metastatic Breast Cancer With a PIK3CA Mutation, After Disease Progression Following Endocrine Therapy as Monotherapy, in the Real-world Setting#1009753ClinicalTrials.gov
• A PhaseⅠ/Ⅱ Study of Simmitinib or Irinotecan Liposomes Combined With DP303c in Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma#836039ClinicalTrials.gov
• A platform for phenotyping disease progression and associated longitudinal risk factors in large-scale EHRs, with application to incident diabetes complications in the UK Biobank#922199eScholarship
• A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3#966461ClinicalTrials.gov
• Salmonella SopB suppresses post-transcriptionally regulated cytokine release to reduce early tissue inflammation and delay disease progression / Nour Diab, Chiun Huei Yong, Eva-Lena Stange, Marlène S. Birk, Matthias A. Schmitz, Stefan Düsterhöft, Jonas Pes, Kira Noemi Ferle, Isabel Karkossa, Kristin Schubert, Jörg Deiwick, Mihael Vucur, Tom Lüdde, Natalia Torow, Andreas Ludwig, Aline Dupont, Joel Selkrig, Martin von Bergen, Michael Hensel, Kaiyi Zhang, Mathias Walter Hornef#629032Deutsche Nationalbibliothek
• EPO-0627 Clinical relevance of evoked potentials for disease progression in early multiple sclerosis and clinically isolated syndrome in the ProVal-MS study [Abstract] / Marie Braun, J. Havla, M. Kowarik, H. Tumani, Lars Behrens, Markus Naumann, H. Zimmermann, J. Kirschke, M. Senel, M. Kerschensteiner, Lino Braadt, Verena Steuerwald, Korbinian Holzapfel, Anna Muzalyova, H. Spengler, M. Mühlau, E. Oswald, M. Hagedorn, B. Sailer, B. Bender, I. Vardakas, N. Sollmann, O. Kohlbacher, H. Kestler, F. Kohlmayer, U. Ziemann, F. Albashiti, Frank Kramer, M. Boeker, P. Uibel, S. Buchka, Iñaki Soto-Rey, Sven Olaf Rohr, U. Mansmann, B. Hemmer, Antonios Bayas#661677Deutsche Nationalbibliothek